About the role

Director supporting Novartis' enterprise strategy for Emerging Therapeutic Strategies. Leading strategic analyses and decision making in emerging technologies and therapeutic opportunities.

Responsibilities

Location: Basel Switzerland or Cambridge MA US.
This role will follow a hybrid working model.
Contribute to the development and refinement of strategic agendas across emerging technologies, pathways, and whitespace opportunities.
Conduct independent research, landscape analysis, and early framing of opportunities where Novartis may expand or refine its position.
Develop clear, insight-driven recommendations that feed into enterprise-level decision-making.
Support preparation for governance engagements (e.g., ECN, IMB, DTB, TAR) and participate as appropriate.
Facilitate cross-functional alignment across BR, Development, Strategy & Growth, and commercial units by driving structured problem-solving, synthesizing diverse inputs.
Ensure materials are well-structured, objective, and aligned to key strategic questions.
Evaluate emerging focus areas, assessing scientific maturity, inflection points, risks, and strategic value.
Identify opportunity gaps and propose internal or external approaches (build, partner, deprioritize) with supporting analyses.
Conduct horizon scanning across priority modalities and pathways, synthesizing competitive, scientific, and market signals into actionable insights.
Engage internal and external stakeholders selectively to deepen understanding of emerging trends, technologies, and partnership opportunities.
Maintain awareness of cutting-edge developments to support ETS strategic foresight and leadership decision-making.

Bachelor's degree required, advanced degree (PhD, MD, or other advanced University degree) or equivalent experience in life science/healthcare; MBA, consulting, or equivalent experience highly desirable.
Highly agile, with the capacity to manage coherent strategic evaluation of diverse and ambiguous scientific and technological subject matter.
Some experience evaluating new product opportunities through M&A, BD&L, and internal research programs.
At least 5-10 years’ experience of pharma industry and/or medical devices.
Experience in conducting, commissioning, and analyzing primary research.
Experience of strategy development and asset shaping early in lifecycle (any functional perspective).
Experience in global roles or with high exposure to those with global responsibility.
Ability to comfortably engage with senior leadership as well as mid-career associates to influence and challenge with excellent interpersonal skills.
Strong financial modeling and valuations skills.
Experience in strategic and competitive data analysis and insights generation, leveraging digital tools.
Strong strategic vision and excellent communication, consensus building and influencing skills.
Enterprise maximization mindset: able to align to broader enterprise strategy for trade-off against shorter-term payoffs to avoid unnecessary investments.
Desire to propose bold choices.
Effectively work in matrix balancing cross-functional perspectives and alignment with business priorities.

Commitment to Diversity and Inclusion: Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Accessibility and Accommodation: Novartis is committed to working with and providing reasonable accommodation to all individuals.